BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 188369)

  • 41. Hydrolytic rupture of ascorbate by adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Lewin S
    Biochem Soc Trans; 1976; 4(1):71-3. PubMed ID: 12036
    [No Abstract]   [Full Text] [Related]  

  • 42. Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum.
    Palmer GC
    Exp Neurol; 1979 Feb; 63(2):322-35. PubMed ID: 220075
    [No Abstract]   [Full Text] [Related]  

  • 43. Stimulation by insulin of cyclic AMP phosphodiesterase. Role of glutathione-insulin transhydrogenase.
    Phelps BH; Varandani PT
    Biochem Biophys Res Commun; 1977 Mar; 75(2):302-10. PubMed ID: 192234
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of levamisole on phosphodiesterase activity.
    Constantopoulos A; Kafasi V; Doulas N; Liakakos D; Matsaniotis N
    Experientia; 1977 Mar; 33(3):395-6. PubMed ID: 192573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
    Menahan LA; Kemp RG
    J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration of phosphodiesterase activity after 5-bromodeoxyuridine (BUdR) treatment of Dictyostelium discoideum.
    Scrive M; Guespin-Michel JF; Felenbok B
    Exp Cell Res; 1977 Aug; 108(1):107-10. PubMed ID: 196866
    [No Abstract]   [Full Text] [Related]  

  • 47. Reciprocal changes in Ca2+/protein activator-dependent and-independent cyclic AMP phosphodiesterase during the development of chick embryos.
    Tanigawa Y; Shimoyama M; Tai J; Fujii K; Ueda I
    Biochem Biophys Res Commun; 1976 Nov; 73(1):19-24. PubMed ID: 187189
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of cortisol on adenylate cyclase and 3',5'-AMP phosphodiesterase activity and 3',5'-AMP concentration in tissues and biological fluids in experimental atherosclerosis].
    Speranskaia NV; Ozerova IN; Shcherbakova IA; Gerasimova EN
    Vopr Med Khim; 1977; (6):777-82. PubMed ID: 202090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy of atherosclerosis.
    Numano F
    Jpn Circ J; 1980 Jan; 44(1):55-68. PubMed ID: 6245288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular cyclic-amp phosphodiesterase regulation in agar plate cultures of Dictyostelium discoideum.
    Gerisch G
    Cell Differ; 1976 Apr; 5(1):21-5. PubMed ID: 177215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of plasma membranes with influenza virus. VII. Effect on 3',5'-cyclic adenosine monophosphate phosphodiesterase activity.
    Krizanová O; Lacinová D; Knopp J
    Acta Virol; 1977 Mar; 21(2):97-103. PubMed ID: 17292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heavy metals and adenosine cyclic 3',5'-monophosphate metabolism: possible relevance to heavy metal toxicity.
    Nathanson JA; Bloom FE
    Mol Pharmacol; 1976 May; 12(3):390-8. PubMed ID: 180396
    [No Abstract]   [Full Text] [Related]  

  • 53. Cyclic AMP metabolism in pigeon arteries: comparison of atherosclerotic-resistant and -susceptible strains.
    Singer AL; Brodie AF
    J Mol Cell Cardiol; 1978 Apr; 10(4):347-61. PubMed ID: 205658
    [No Abstract]   [Full Text] [Related]  

  • 54. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions.
    Soderling SH; Beavo JA
    Curr Opin Cell Biol; 2000 Apr; 12(2):174-9. PubMed ID: 10712916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation, by insulin, of lipoprotein lipase and phosphodiesterase activities in rat adipose tissue.
    Desai K; Hollenberg CH
    Isr J Med Sci; 1975 Jun; 11(6):540-50. PubMed ID: 169209
    [No Abstract]   [Full Text] [Related]  

  • 56. Adenosine 3':5'-cyclic monophosphate phosphodiesterase activity in the dystrophic rat retina.
    Dewar AJ; Barron G; Richmond J
    Biochem Soc Trans; 1975; 3(2):265-8. PubMed ID: 165991
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential effects of prostaglandin synthetase inhibitors on prostaglandin E2 binding and on prostaglandin- or cholera toxin-induced cyclic AMP accumulation in the rabbit uterus.
    Zor U; Koch R; Naor Z
    Adv Prostaglandin Thromboxane Res; 1976; 1():331-5. PubMed ID: 187046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
    Bocek RM; Beatty CH
    Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
    [No Abstract]   [Full Text] [Related]  

  • 59. Adenylate cyclase and phosphodiesterase in transitional epithelium of the urinary bladder.
    Chlapowski FJ
    Life Sci; 1976 Feb; 18(3):351-9. PubMed ID: 176554
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence for differences in protein kinase modulator and and phosphodiesterase activator.
    Miyamoto E; Hideshima Y; Teshima Y; Yamazaki R; Kakiuchi S
    J Cyclic Nucleotide Res; 1977 Apr; 3(2):85-94. PubMed ID: 195987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.